Codexis Inc (CDXS) Stock Analysis

Codexis Inc (CDXS) is a publicly traded company in the HEALTHCARE sector. It trades at $2.69, carries a market capitalization of $242.69M. This page summarizes the public market data, fundamentals, and frequently asked questions for CDXS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.69
• Market Cap: $242.69M
• EPS: $-0.35
• 52-Week High: $3.87
• 52-Week Low: $0.96

Market Sentiment

Codexis Inc currently has a Bullish sentiment score of 0.25.

About Codexis Inc

Codexis, Inc. is an innovative biotechnology company based in Redwood City, California, focused on the discovery, development, and commercialization of advanced biocatalysts that drive more sustainable manufacturing across diverse sectors, including pharmaceuticals, chemicals, and food. Utilizing its proprietary enzyme technology and cutting-edge protein engineering techniques, Codexis enhances enzyme performance, establishing itself as a leader in biocatalyst applications. As global industri...

GNG Research Analysis

GNG Research scores Codexis Inc (CDXS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CDXS.

Frequently Asked Questions

Does CDXS pay dividends?

Codexis Inc (CDXS) does not currently pay a regular dividend.

What is CDXS's market cap?

Codexis Inc (CDXS) has a market capitalization of $242.69M with a current stock price of $2.69.